Table 1.
Characteristics of the study participants (N = 3776)
| Demographic characteristics | No-NAFLD (n = 1,787) | NAFLD (n = 1,989) | P-value |
|---|---|---|---|
| Gender (male/female) | 858/929 | 868/1121 | 0.007 |
| Age (years) | 72.76 ± 6.65 | 72.18 ± 6.33 | 0.002 |
| Diabetes (no/yes) | 1575/212 | 1650/551 | < 0.001 |
| SBP (mmHg) | 140.06 ± 22.28 | 144.89 ± 20.73 | < 0.001 |
| DBP (mmHg) | 83.20 ± 12.01 | 85.80 ± 10.99 | < 0.001 |
| BMI (kg/m2) | 22.51 ± 2.92 | 25.82 ± 2.96 | < 0.001 |
| ALB (g/L) | 44.54 ± 2.74 | 45.06 ± 2.70 | < 0.001 |
| ALT (U/L) | 15.04 ± 11.13 | 18.24 ± 11.58 | < 0.001 |
| AST (U/L) | 19.62 ± 7.30 | 20.01 ± 7.46 | 0.113 |
| RBC (1012/L) | 4.43 ± 0.45 | 4.56 ± 0.43 | < 0.001 |
| Urea (mmol/L) | 5.85 ± 1.57 | 5.68 ± 1.42 | 0.001 |
| FPG (mmol/L) | 5.46 ± 1.85 | 5.74 ± 1.92 | < 0.001 |
| HGB (g/L) | 133.78 ± 13.71 | 137.60 ± 12.97 | < 0.001 |
| PLT (109/L) | 194.81 ± 47.30 | 199.51 ± 47.89 | 0.002 |
| TC (mmol/L) | 4.74 ± 0.92 | 4.89 ± 0.91 | < 0.001 |
| TB (umol/L) | 11.04 ± 4.53 | 11.10 ± 4.55 | 0.653 |
| CRE (umol/L) | 76.65 ± 18.91 | 75.76 ± 18.41 | 0.142 |
| LDL (mmol/L) | 3.01 ± 0.79 | 3.13 ± 0.80 | < 0.001 |
| TG (mmol/L) | 1.15 ± 0.72 | 1.61 ± 0.99 | < 0.001 |
| UA (umol/L) | 290.02 ± 80.89 | 314.37 ± 1.87 | < 0.001 |
| AFP (ng/mL) | 5.48 ± 4.62 | 5.35 ± 3.66 | 0.321 |
| LYMPH (109/L) | 1.92 ± 0.60 | 2.10 ± 0.62 | < 0.001 |
| NEUT (109/L) | 3.46 ± 1.15 | 3.65 ± 1.13 | < 0.001 |
LDL Low-density lipoprotein level, BMI Body mass index, AST Aspartate aminotransferase level, RBC Red blood cell count, Urea Urea level, FPG Fasting plasma glucose, HGB Hemoglobin, PLT Platelet count, TC Total cholesterol, TB Total bilirubin, ALB Albumin level, CRE Creatinine level, TG Triglyceride level, UA Uric acid level; DBP Diastolic blood pressure, AFP Alpha-fetoprotein level, LYMPH Lymphocyte count, SBP Systolic blood pressure, NEUT Neutrophil count, ALT Alanine transaminase level